Literature DB >> 30191506

Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of One Case and Review of the Literature.

Zhenjian Cai1, Mei Lin1, Angel I Blanco2, Jing Liu1, Hui Zhu3.   

Abstract

Epstein-Barr Virus (EBV)-positive neuroendocrine carcinoma (NEC) of the nasopharynx is exceedingly rare, only two cases have been reported in the literature. While EBV infection is strongly associated with nasopharyngeal carcinoma, which is carcinoma with squamous differentiation, the link between EBV and NEC is not well known, and can be diagnostically challenging. In this study, we report the third case of EBV-positive large cell NEC of nasopharynx with neck lymph node metastasis. The patient was treated with combined radiation and chemotherapy and showed complete clinical and radiological response. Similar treatment response has been reported in another patient with high stage EBV-positive large cell NEC, suggesting that EBV status is an important prognostic factor. Recognition of this rare tumor is important for disease management and patient prognosis. We also review the literature about the clinical and pathologic presentation of neuroendocrine tumors of nasopharynx.

Entities:  

Keywords:  Epstein–Barr virus; Nasopharyngeal carcinoma; Nasopharynx; Neuroendocrine carcinoma

Mesh:

Year:  2018        PMID: 30191506      PMCID: PMC6684828          DOI: 10.1007/s12105-018-0963-x

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  2 in total

Review 1.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.

Authors:  Ozgur Mete; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2022-03-21

2.  Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.

Authors:  Ying-Peng Peng; Qiao-Dan Liu; Yu-Jing Lin; Shun-Li Peng; Rong Wang; Xi-Wei Xu; Wei Wei; Gui-Hua Zhong; Yu-Ling Zhou; Ya-Qin Zhang; Ye Liu; Si-Yang Wang; Hai-Yu Hong; Zhi-Gang Liu
Journal:  Radiat Oncol       Date:  2021-10-11       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.